Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1984 1
1985 3
1986 3
1987 2
1988 2
1991 2
1993 2
1994 5
1995 4
1996 4
1997 5
1998 10
1999 11
2000 6
2001 3
2002 7
2003 7
2004 9
2005 8
2006 4
2007 8
2008 9
2009 7
2010 9
2011 7
2012 8
2013 8
2014 8
2015 7
2016 16
2017 14
2018 8
2019 9
2020 12
Text availability
Article attribute
Article type
Publication date

Search Results

210 results
Results by year
Filters applied: . Clear all
Page 1
Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy.
Obeso JA, Stamelou M, Goetz CG, Poewe W, Lang AE, Weintraub D, Burn D, Halliday GM, Bezard E, Przedborski S, Lehericy S, Brooks DJ, Rothwell JC, Hallett M, DeLong MR, Marras C, Tanner CM, Ross GW, Langston JW, Klein C, Bonifati V, Jankovic J, Lozano AM, Deuschl G, Bergman H, Tolosa E, Rodriguez-Violante M, Fahn S, Postuma RB, Berg D, Marek K, Standaert DG, Surmeier DJ, Olanow CW, Kordower JH, Calabresi P, Schapira AHV, Stoessl AJ. Obeso JA, et al. Among authors: Standaert DG. Mov Disord. 2017 Sep;32(9):1264-1310. doi: 10.1002/mds.27115. Mov Disord. 2017. PMID: 28887905 Free PMC article. Review.
Inhibition of the JAK/STAT Pathway Protects Against α-Synuclein-Induced Neuroinflammation and Dopaminergic Neurodegeneration.
Qin H, Buckley JA, Li X, Liu Y, Fox TH 3rd, Meares GP, Yu H, Yan Z, Harms AS, Li Y, Standaert DG, Benveniste EN. Qin H, et al. Among authors: Standaert DG. J Neurosci. 2016 May 4;36(18):5144-59. doi: 10.1523/JNEUROSCI.4658-15.2016. J Neurosci. 2016. PMID: 27147665 Free PMC article.
Cannabidiol improves frequency and severity of seizures and reduces adverse events in an open-label add-on prospective study.
Szaflarski JP, Bebin EM, Cutter G, DeWolfe J, Dure LS, Gaston TE, Kankirawatana P, Liu Y, Singh R, Standaert DG, Thomas AE, Ver Hoef LW; UAB CBD Program. Szaflarski JP, et al. Among authors: Standaert DG. Epilepsy Behav. 2018 Oct;87:131-136. doi: 10.1016/j.yebeh.2018.07.020. Epub 2018 Aug 9. Epilepsy Behav. 2018. PMID: 30100226 Free article. Clinical Trial.
Levodopa-carbidopa intestinal gel in advanced Parkinson's disease: final 12-month, open-label results.
Fernandez HH, Standaert DG, Hauser RA, Lang AE, Fung VS, Klostermann F, Lew MF, Odin P, Steiger M, Yakupov EZ, Chouinard S, Suchowersky O, Dubow J, Hall CM, Chatamra K, Robieson WZ, Benesh JA, Espay AJ. Fernandez HH, et al. Among authors: Standaert DG. Mov Disord. 2015 Apr;30(4):500-9. doi: 10.1002/mds.26123. Epub 2014 Dec 24. Mov Disord. 2015. PMID: 25545465 Free PMC article. Clinical Trial.
Peripheral monocyte entry is required for alpha-Synuclein induced inflammation and Neurodegeneration in a model of Parkinson disease.
Harms AS, Thome AD, Yan Z, Schonhoff AM, Williams GP, Li X, Liu Y, Qin H, Benveniste EN, Standaert DG. Harms AS, et al. Among authors: Standaert DG. Exp Neurol. 2018 Feb;300:179-187. doi: 10.1016/j.expneurol.2017.11.010. Epub 2017 Nov 16. Exp Neurol. 2018. PMID: 29155051 Free PMC article.
Long-term safety and efficacy of levodopa-carbidopa intestinal gel in advanced Parkinson's disease.
Fernandez HH, Boyd JT, Fung VSC, Lew MF, Rodriguez RL, Slevin JT, Standaert DG, Zadikoff C, Vanagunas AD, Chatamra K, Eaton S, Facheris MF, Hall C, Robieson WZ, Benesh J, Espay AJ. Fernandez HH, et al. Among authors: Standaert DG. Mov Disord. 2018 Jul;33(6):928-936. doi: 10.1002/mds.27338. Epub 2018 Mar 23. Mov Disord. 2018. PMID: 29570853 Clinical Trial.
Invisible Killers.
Volpicelli-Daley LA, Standaert DG. Volpicelli-Daley LA, et al. Among authors: Standaert DG. Mov Disord. 2016 Jan;31(1):44. doi: 10.1002/mds.26465. Epub 2016 Jan 9. Mov Disord. 2016. PMID: 26748962 No abstract available.
Ser(P)-1292 LRRK2 in urinary exosomes is elevated in idiopathic Parkinson's disease.
Fraser KB, Rawlins AB, Clark RG, Alcalay RN, Standaert DG, Liu N; Parkinson's Disease Biomarker Program Consortium, West AB. Fraser KB, et al. Among authors: Standaert DG. Mov Disord. 2016 Oct;31(10):1543-1550. doi: 10.1002/mds.26686. Mov Disord. 2016. PMID: 27297049 Free PMC article.
Biomarkers in Parkinson's disease: From pathophysiology to early diagnosis.
Calabresi P, Standaert DG, Chiasserini D, Parnetti L. Calabresi P, et al. Among authors: Standaert DG. Mov Disord. 2016 Jun;31(6):769-70. doi: 10.1002/mds.26683. Mov Disord. 2016. PMID: 27245116 No abstract available.
Strength of cholinergic tone dictates the polarity of dopamine D2 receptor modulation of striatal cholinergic interneuron excitability in DYT1 dystonia.
Scarduzio M, Zimmerman CN, Jaunarajs KL, Wang Q, Standaert DG, McMahon LL. Scarduzio M, et al. Among authors: Standaert DG. Exp Neurol. 2017 Sep;295:162-175. doi: 10.1016/j.expneurol.2017.06.005. Epub 2017 Jun 3. Exp Neurol. 2017. PMID: 28587876 Free PMC article.
210 results
Jump to page